Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	84.27	102.76	55.77
Graham Fair Price	63.27	9.41	5.76
PEG	-87.96	-0.08	0.68
Price/Book	6.71	3.66	3.43
Price/Cash Flow	102.05	-49.28	24.39
Prices/Earnings	-59.98	30.28	-75.67
Price/Sales	9.79	1.91	1.74
Price/FCF	102.05	-49.28	24.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	53.45	0.03	0.02
Operating Margin	63.69	0.01	< 0.005
ROA	179.11	< 0.005	< 0.005
ROE	-0.01	0.03	166.67
ROIC	0.01	< 0.005	-57.27
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.20	96.06
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-1.11	2.60	133.25
EPS QOQ	-1.11	3.69	232.31
FCF QOQ	11.50	-1.53	-86.69
Revenue QOQ	-0.04	-0.02	37.61
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	50.14	50.64	1.01
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.38	0.37	-2.96
Quick Ratio	1.49	1.53	2.64
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.41	11.41	-0.02
Cash	15.22	14.09	-7.46
Capex	-0.21	-0.20	3.43
Free Cash Flow	1.61	-0.85	-47.20
Revenue	22.47	21.84	-2.82
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.60	1.67	4.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-14.33	-20.45	-42.73
Naive Interpretation	Member

06 - Financial Health · Weak

Rating